StockGlow

ACADIA Pharmaceuticals Inc. (DR6.F)

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.

23.02+0.01%Healthcare
Compare DR6.F with
StockGlow Score
97
Bullish
BearishBullish
1 year ago+12.8%

The outlook

ACADIA Pharmaceuticals Inc. currently reads as bullish based on above its 50- & 200-day averages, 100% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range100% of the way from its 52-week low to high
Market cap
$3.94B
52-wk high
23.02
52-wk low
17.52
50-day avg
20.26
200-day avg
19.64
Trailing P/E
11.9

Similar stocks

2L9.FVisionWave Holdings, Inc.$1.70+0.00%UP0.FUltragenyx Pharmaceutical Inc.$22.52+4.89%KK3A.FCytokinetics, Incorporated$69.26-1.34%NKB2.FTG Therapeutics, Inc.$46.00-0.43%J7Z.FJazz Pharmaceuticals plc$223.30+0.00%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy